Where you live shouldn’t determine whether you live. But too often it does. The average child born in a high-income country today will live nearly 18 years longer than a child born in a low-income country.
This is not a coincidence. Health and well-being are inextricably linked with poverty.
Increasing access to health services and life-saving tools, like vaccines and medicine, in low-income countries has the potential to improve lives and help disrupt this cycle of poverty.
Globally, about 60 million people die each year. But why people die and what risk factors lead to early death vary dramatically between countries. Non-communicable diseases, like chronic or cardiovascular conditions account for the majority of deaths in higher-income countries while infectious diseases are still among the leading causes of death in the world’s poorest countries. These diseases are also more likely to be associated with early death despite being completely preventable and treatable. Expanding access to primary health care and scaling interventions for the biggest diseases killers in low- and lower-middle income countries would save lives now and increase life expectancy over time.
Six of the top 10 causes of death in low-income countries are preventable infectious diseases.
These deaths are concentrated in the world’s poorest countries. Only one of these conditions (lower respiratory infections) appears in the top 10 for higher-income groups.
These deaths are completely preventable and treatable with better access to health services and health technologies like vaccines and medicine.
The global response to HIV/AIDS is a model for what’s possible when political will and funding are consistently directed toward a global health crisis. At its peak in 2004, AIDS was killing almost 5,479 people every day and new HIV infections doubled each year. Today that number has been reduced to 1,726 deaths a day. In 2022, 39.0 million people were living with HIV around the world, 53% of whom are women and girls.
The global AIDS epidemic is still growing at an alarming pace. In 2022, 1.3 million people were newly infected with HIV globally. The pace of progress is well short of where it needs to be to end AIDS as a public health threat by 2030.
For millions of people around the world, a mosquito bite can have deadly consequences. Malaria is a tropical disease caused by parasites and transmitted through the bite of an infected Anopheles mosquito. About 95% of malaria cases and deaths globally occur in sub-Saharan Africa; just four African countries accounted for half of all malaria deaths worldwide (Nigeria, DRC, Tanzania, Mozambique). Control measures such as indoor residual spraying with insecticides, insecticide-treated bed nets, and antimalarial drugs have successfully reduced malaria cases and deaths. However, insecticide- and drug-resistance is a growing threat as these interventions continue to be scaled up. A promising new malaria vaccine recommended by WHO in 2021 could dramatically increase protection if successfully scaled up.
Over 600,000 people died from malaria in 2020.
In 2020, 95% percent of malaria cases and 96% of malaria deaths occurred in Africa.
Children under 5 accounted for about 80% of all malaria deaths in the region.
Vaccines are one of the most cost-effective investments in health and development in history. They safely prevent sickness and death associated with infectious diseases and contribute to broader gains in education and economic development. But 1.5 million people are still dying from vaccine-preventable diseases. And climate change, conflict and urbanisation are together making it easier for infectious disease outbreaks to spread. In 2022, for the first time in three decades, global vaccination coverage among children declined. The backslide is being driven by disruptions caused by COVID-19, conflict, displacement and increasing vaccine misinformation. As a result, 25 million children are missing out on life-saving vaccines every year, placing them at risk from preventable diseases like measles and polio. The most poor and marginalised children – often most in need of vaccines – continue to be the least likely to get them.
Coverage of the diphtheria tetanus toxoid and pertussis (DTP3) vaccine is considered a proxy for routine childhood immunisation. A child who receives all three doses before turning one likely has regular access to health services.
Globally, coverage of DTP3 has improved dramatically in the last 20 years. In 2020, over 50% more children were immunised with DTP3 in lowest-income countries than in 2000.
But for the first time in three decades, global vaccination coverage among children declined in 2021.
Financing for health in low-income countries has increased steadily over the past 20 years, but a closer look at the major sources of financing reveals some concerning trends: international support from donor countries is stagnant, domestic resources are not keeping pace with need, and people in the poorest countries, many of which are in sub-Saharan Africa, are far too often forced to pay for essential health services out of their own pockets.
Domestic health spending in sub-Saharan Africa more than doubled, in absolute terms, between 2000 and 2018. But development assistance for health (DAH) has significantly outpaced the growth of domestic health financing.
This surge in development assistance for health was driven largely by donor investments in HIV/AIDS, TB, malaria and maternal and child health, but since 2018 has been largely stagnated.
Use the dropdown to see total or per person figures.
Estimates suggest that low income countries should spend at least 5% of their GDP and $86 per capita to ensure that all citizens have access to primary healthcare services.
16 countries in Africa met the $86 per capita target.
But only 12 African countries met both targets.